6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Latest Press Releases

Time	Headline
21m ago	CC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
54m ago	Canadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
54m ago	Waraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
54m ago	Sierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
54m ago	First Quantum Minerals Reports First Quarter 2026 Results

About

Lenz Therapeutics Inc (NASDAQ:LENZ) — investor relations, events, news, and company updates on 6ix.

Latest News

LENZ Therapeutics Announces Submission of Marketing Authorization Application to the Medicines and Healthcare products Regulatory Agency for VIZZ® for the Treatment of Presbyopia in the United Kingdom

LENZ Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights

LENZ Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights on March 24, 2026

LENZ Therapeutics Announces Submission of Marketing Authorization Application to European Medicines Agency for VIZZ® for the Treatment of Presbyopia

LENZ Therapeutics and Sarah Jessica Parker announce the launch of “Make it VIZZable”, the VIZZ consumer campaign

Financials

Revenue

$19.09 M

Market Cap

$291.28 M

EPS

-2.85

Community Chat

Ask AI